(1)
Idamakanti, M.; Bijjam, R. I.; Kumar, M.; Mukkamalla, S. K. Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review. J Med Cases 2025, 16 (6), 212-221. https://doi.org/10.14740/jmc5136.